4 The Guideline Development Group, National Collaborating Centre and NICE project team

4 The Guideline Development Group, National Collaborating Centre and NICE project team

4.1 Guideline Development Group

The Guideline Development Group members listed are those for the 2015 update. For the composition of previous Guideline Development Groups, see the full guideline.

Christopher Brown
Highly Specialist Clinical Lead Pharmacist for Nephrology, Abertawe Bro Morgannwg University Health Board, Swansea

Roy Connell
Clinical Nurse Specialist, Children's Renal and Urology Unit, Nottingham University Hospitals

Jan Cooper
Patient and Carer Member, Kidney Research UK and Kidney Patients Association West Midlands Renal Network

Mark Devonald
Consultant Nephrologist, Nottingham University Hospitals

Belinda Dring
Anaemia Nurse Specialist, Nottingham University Hospitals

Damian Fogarty
Senior Lecturer and Consultant Nephrologist, Queen's University Belfast and Chairman, United Kingdom Renal Registry

Kathryn Griffith
General Practitioner, Unity Health, York

Ashraf Mikhail
Consultant Renal Physician, Morriston Hospital, Swansea

Nicholas Palmer
Patient and Carer Member, National Kidney Federation

Mark Prentice
Advance Renal Nurse Practitioner, James Paget University Hospital, Great Yarmouth

Laura Ratcliffe
Specialist Trainee, Department of Physiology and Pharmacology, University of Bristol

Suzanne Stephens
Consultant Paediatric Nephrologist, Birmingham Children's Hospital

Mark Thomas (Chair)
Consultant Physician and Nephrologist, Heart of England NHS Foundation Trust

Wayne Thomas
Consultant Haematologist, Derriford Hospital, Plymouth

4.2 National Clinical Guideline Centre

Susan Latchem (until November 2014)
Operations Director and Guideline Lead

Smita Padhi
Senior Research Fellow

Jessica Glen
Research Fellow

Grace Marsden (until June 2014)
Senior Health Economist

David Wonderling
Head of Health Economics (from June 2014)

Guideline Lead (from November 2014)

Saoussen Ftouh (until March 2014)
Senior Research Fellow/Project Manager

Ben Pordes (from April 2014)
Project Manager

Bethany King (from July 2014)
Document Editor/Process Assistant

Joanna Ashe
Information Scientist

4.3 NICE project team

Sarah Willett
Guideline Lead

Martin Allaby
Clinical Adviser

Louise Shires
Guideline Commissioning Manager

Joy Carvill
Guideline Coordinator

Beth Shaw
Technical Lead

Paul Crosland
Health Economist

Annette Mead
Editor

4.4 Declarations of interests

The following members of the Guideline Development Group made declarations of interests. All other members of the Group stated that they had no interests to declare. The conflicts of interest policy (2007) was followed until September 2014, when an updated policy was published.

Member

Interest declared

Type of interest

Decision taken

Mark Thomas (Chair)

Local investigator for an Amgen sponsored trial of fortnightly versus monthly darbepoetin dosing in CKD. This has resulted in standard trial fees paid into the departmental Research Fund for research nurse, physician and other costs. The last invoice was paid in May 2012. He has been UK chief investigator for this multinational study, a role that is nominal as it has not required any work or resulted in any payment.

Non‑personal, non‑specific pecuniary

Declare and participate

Mark Thomas (Chair)

Local investigator for a Vifor sponsored RCT of intravenous Ferinject (ferric carboxymaltose) versus oral iron therapy in treatment of iron deficiency of CKD (the FIND‑CKD study). This has resulted in standard trial fees paid into the departmental Research Fund for research nurse, physician and other costs.

Non‑personal, specific pecuniary

Passed responsibility for the trial to a colleague

Mark Thomas (Chair)

Attended a meeting at the Birmingham Nephology Club, sponsored by Amgen, which included a meal, on 03/07/2014.

Personal, non‑specific pecuniary

Declare and participate

Mark Thomas

(Chair)

His department is involved in PIVOTAL.

Non‑personal specific pecuniary

Declare and participate

Roy Connell

Organised the paediatric nephrology nurses conference (March 2014) at which Amgen contributed to the cost of hosting the education day.

Non‑personal, non‑specific, pecuniary

Declare and participate

Mark Devonald

He was sponsored by Janssen to attend the American Society of Nephrology meeting in November 2012.

Personal, non‑specific pecuniary

Declare and participate

Mark Devonald

He is the organiser of the Nottingham acute kidney injury course which received unrestricted educational grants from MSD, Amgen, Boehringer Ingelheim and Shire.

Non‑personal, non‑specific pecuniary

Declare and participate

Mark Devonald

He is organising an Acute Kidney Injury course which is sponsored by Amgen who manufacture ESAs. The funding is specifically for the course and he will not be receiving any money.

Non‑personal, non‑specific, pecuniary

Declare and participate

Belinda Dring

Between October 2012 and March 2013: she has undertaken consultancy work for Takeda providing 2 teaching sessions on renal anaemia and processes to negotiate tariff to the sales team. She has also had sponsorship from Janssen–Cilag to attend British Renal Society. She is also an executive member of Anaemia Nurse Specialist Association (ANSA).

Personal, non‑specific pecuniary

Declare and participate

Belinda Dring

Co‑wrote an article for the Nursing Times on CKD published in the February 2015 issue of the Nursing Times. Received a payment.

Personal, non‑specific, pecuniary

Declare and participate

Damian Fogarty

He has previously delivered educational lectures for various pharmaceutical companies on the epidemiology and generic management of CKD and diabetic nephropathy. These were paid by modest honoraria to him directly and were delivered largely to GPs but occasionally related medicine and surgical specialities such as diabetes and vascular surgery. He has also been invited to consultancy and advisory boards on an ad hoc basis usually once per annum. These were also paid by modest honoraria to him directly.

Personal, non‑specific, pecuniary

Declare and participate

Damian Fogarty

He attended an investigators' meeting for the PIVOTAL trial of IV iron. This was for Belfast to participate as a recruitment centre.

Non‑personal, non‑specific, pecuniary

Declare and participate

Kathryn Griffith

25/9/13 Speaker at meeting in Birmingham on atrial fibrillation. Fee and travel expenses paid by Omnium Medical Meetings.

26/9/13 Speaker at BMJ Masterclass in Manchester with fee and travel paid by BMJ Education.

2/10/13 Speaker at meeting in Bradford on anticoagulation choices for atrial fibrillation. Travel and fee paid by Leeds University pharmacy course.

Personal, non‑specific, pecuniary

Declare and participate

Kathryn Griffith

7/9/13 Speaker at meeting on atrial fibrillation arranged by EH Medical Meetings. But sponsored by Bayer. Fee paid to The Society for Professionals with an interest in Cardiovascular Disease in General Practice (CVGP).

8/10/13 Speaker at primary care meeting on atrial fibrillation. Fee paid to Unity Health by Boehringer Ingelheim.

Non‑personal, non‑specific, pecuniary interest

Declare and participate

Kathryn Griffith

14/9/13 Speaker at CVGP meeting in Cambridge sponsored by CVGP and accommodation provided by CVGP.

14/10/13 Attended Northern Lights meeting of CVGP which was sponsored by Pfizer but paid for own refreshments and travel.

Personal, non‑specific, non‑pecuniary

Declare and participate

Kathryn Griffith

Attended the American College of Cardiology in Washington 28–31 March 2014. Travel and accommodation were funded by Boehringer Ingelheim.

Personal, non‑specific, pecuniary

Declare and participate

Ashraf Mikhail

He received travel bursary from Johnson & Johnson to attend the European Dialysis and Transplant Association meeting in July 2013.

He also helped Xenetics Bio to design a phase II trial in January 2013.

He is a member of the Clinical Research Centre (anaemia) within Kidney Research UK

He is a co‑author on the Renal Association anaemia clinical practice guidelines.

Personal, non‑specific, pecuniary

Declare and participate

Ashraf Mikhail

Attended a Kidney Disease Improving Global Outcomes (KDIGO) conference on 'Controversies in iron management'. His food and accommodation were provided by KDIGO.

Personal, non‑specific, pecuniary

Declare and participate

Ashraf Mikhail

Principle investigator of the PHARMACOSMOS 'Quality of life after IV iron in CK patients' phase III study starting in January 2015, after guideline development.

Principle investigator of the Astellas 'hypoxia inducible factor for anaemia in dialysis patients' phase III study starting in March 2015.

Personal, specific, pecuniary

Declare and participate

Nicholas Palmer

Attended a Baxter‑sponsored home dialysis round table discussion in October 2012. His hotel accommodation was paid for and he received a small fee.

He also attended World Kidney Day event in March 2013 at Sanofi to provide information on CKD and acute kidney injury. His expenses were paid.

He attended a Fresenius sponsored discussion on commissioning in March/April 2013. He was paid a small fee for attending.

Personal, non‑specific, pecuniary

Declare and participate

Nicholas Palmer

Attended a holiday dialysis conference in Barcelona sponsored by Diaverum. He gave a talk at this event. The company paid for his accommodation, lunch and dinner.

Personal, non‑specific, pecuniary

Declare and participate

Nicholas Palmer

Attended Sanofi global meeting in Dubrovnik at the end of March/April and presented 'A patient's journey with CKD'. Expenses/transport and hotel were paid for.

Personal, non‑specific, pecuniary

Declare and participate

Suzanne Stephens

Her husband is an adult haematologist and has been an advisor for Boehringer Ingelheim for work on dabigatran and has given a talk for Pfizer regarding apixaban.

Non‑specific, family

Declare and participate

Wayne Thomas

Invited speaker at Sysmex Annual User Meeting. Accommodation and transport paid, but not paid to speak. Subject will be on functional iron deficiency in professional capacity – already written paper (2013).

Personal, non‑specific, pecuniary

Declare and participate

  • National Institute for Health and Care Excellence (NICE)